Related Experiment Video
Updated: Jul 6, 2026
06:51
Microfluidic Model of Necrotizing Enterocolitis Incorporating Human Neonatal Intestinal Enteroids and a Dysbiotic Microbiome
Published on: July 28, 2023
Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention
Patricia W Lin1, Tala R Nasr, Barbara J Stoll
1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. patricia_lin@oz.ped.emory.edu
Seminars in Perinatology
|March 19, 2008
Summary
Necrotizing enterocolitis (NEC) is a severe intestinal disease in premature infants. Further research into intestinal defenses, gut bacteria, and genetics is crucial for improved prevention and treatment strategies.
Area of Science:
- Neonatal Medicine
- Gastroenterology
- Pediatric Surgery
Background:
- Necrotizing enterocolitis (NEC) is a significant cause of illness and death in neonatal intensive care units.
- NEC disproportionately affects premature infants, presenting a major clinical challenge.
Purpose of the Study:
- To review the current epidemiology and pathophysiology of NEC.
- To highlight recent research findings and identify future research directions for NEC.
Main Methods:
- Literature review focusing on epidemiology, pathophysiology, and recent advancements in NEC research.
- Analysis of current understanding of NEC pathogenesis and treatment limitations.
Main Results:
- NEC remains a devastating and unpredictable condition in premature infants.
- The exact pathogenesis of NEC is still not fully understood.
- Current prevention and treatment strategies for NEC are limited.
Conclusions:
- Understanding premature intestinal defenses is key to improving NEC outcomes.
- Investigating the role of commensal and probiotic bacteria may offer new therapeutic avenues.
- Exploring potential genetic predispositions could enhance NEC prevention and treatment strategies.
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:07Intestinal Obstruction II: Pathophysiology
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...